CCL2 and diabetes mellitus: Circulating MCP-1 is found to be significantly increased in patients with type II diabetes [16–18], this study confirmed macrophage secreted MCP-1 under LPS plus PA treatment, so increased MCP-1 in diabetes with obesity is at least partly from macrophage secretion.